Keep your smile beautiful and stay healthy by taking care of your teeth! There is a direct relationship between your overall health and dental health so http://wwwWatchMojo.com learns the proper technique to keeping your teeth perfect and about a dental clinic with you in mind. Founded in 2003 by Dr. Pierre Comeau, this high-end dental clinic is a unique concept that offers you services characterized by privacy, comfort, and intimacy. Equipped with cutting-edge technology, its mission is to answer your highest criteria in matters of appearance, health, and well-being.
Your toothbrush can fight diabetes, prevent heart problems and even lower your risks for cancer!
White teeth are a new fashion trend appearing on the red carpet. The good news is that you don’t need to spend money on expensive procedures and products for a perfect smile.
Here are eight steps to brush up on at home for perfect teeth.
WALTHAM, Mass., Feb. 27 /PRNewswire/ — According to Millennium Research Group’s US Surgical Procedure Volumes 2008 report, dental implants and facial aesthetic procedures are both growing at over 15% compound annual growth rates (CAGR). This stands in stark contrast to non-cosmetic procedures, which are only growing at CAGRs of under 5%. Aesthetically conscious Americans are demanding cosmetic procedures due to a strong societal focus on good looks and an increased public acceptance of cosmetic enhancement procedures.
Dental implant procedures will expand at a CAGR of over 18% from 2008 to 2011. These procedures will experience particularly high growth due to patients’ desire for aesthetically pleasing and healthy teeth, technological improvements of current dental implant devices, and greater awareness among general practitioners who can perform dental implant procedures.
“Facial aesthetic procedures will grow more than 15% over the next five years,” says Jaya Classen, Senior Analyst at Millennium Research Group. “While non-cosmetic procedures are typically limited to those that are afflicted with a disease or infirmity, cosmetic procedures face no such demographic barriers to growth-the number of people seeking to improve their looks seems endless.”
Millennium Research Group’s US Surgical Procedure Volumes 2008 report covers over 200 different procedures, including anesthesiology, cardiovascular, dental, diagnostic imaging, endoscopy, general surgery, gynecology, neurosurgery, ophthalmology, orthopedics, urology, and varicose vein procedures. Millennium Research Group also has similar coverage of Japanese and European surgical procedure volumes.
About Millennium Research Group
Millennium Research Group (http://www.MRG.net), a Decision Resources, Inc. company (http://www.DecisionResources.com), is the global authority on medical technology market intelligence and a leading provider of strategic information to the health care sector. Focused solely on the medical device, pharmaceutical, and biotechnology industries, the company provides its clients with the benefits of its specialized industry expertise through published reports and customized consulting services.
Everyone knows that sodas/soft drinks aren’t exactly a good addition to your diet, but the prevailing wisdom is that diet sodas are less bad.
A new study obviously had to shatter that:
Sodas — even diet ones — may be linked with increased risk factors for heart disease and diabetes, U.S. researchers said on Monday.
They found adults who drink one or more sodas a day had about a 50 percent higher risk of metabolic syndrome — a cluster of risk factors such as excessive fat around the waist, low levels of “good” cholesterol, high blood pressure and other symptoms.
“When you have metabolic syndrome, your risk of developing heart disease or stroke doubles. You also have a risk of developing diabetes,” said Dr. Ramachandran Vasan of Boston University School of Medicine, whose work appears in the journal Circulation.
Prior studies have linked consumption of sugar-laden sodas with multiple risk factors for heart disease, but Vasan and colleagues also found the link extends to diet sodas.
The study included about 6,000 middle-aged men and women who were observed over four years.
Those who drank one or more soft drinks a day had a 31 percent greater risk of becoming obese.
They had a 30 percent increased risk of developing increased waist circumference — which has been shown to predict heart disease risk better than weight alone.
They also had a 25 percent increased risk of developing high blood triglycerides as well as high blood sugar, and a 32 percent higher risk of having low high-density lipoprotein or “good” cholesterol levels.
Read more.
OTTAWA, ONTARIO–(Marketwire - July 6, 2007) - Further to a warning issued on June 29, Health Canada is warning Canadians not to use a counterfeit product falsely labelled as Colgate Fluoride Toothpaste Maximum Cavity Protection. Ongoing testing has resulted in preliminary evidence of a further, potentially harmful bacterial contamination. If confirmed, the presence of this bacterium could pose a serious health risk.
Health Canada will notify Canadians if it is determined that there is a health risk once final testing is completed.
Consumers who have this counterfeit product are advised to discontinue use immediately and not to use their toothbrush. The product should be kept out of the reach of children. Consumers should seal the tube and put the tube in a sealed bag. They should also wash their hands after handling the tube. Health Canada will provide additional instructions on the proper disposal of the product if needed.
Consumers who have this product should contact Health Canada’s Health Products and Food Branch Inspectorate at 1-800-267-9675.
The counterfeit product falsely labelled as Colgate Fluoride Toothpaste Maximum Cavity Protection is marked as 100 ml, and is labelled as “Manufactured in South Africa.” It contains misspellings including “isclinically” “SOUTH AFRLCA” and “South African Dental Assoxiation.”
This counterfeit toothpaste product was found in the discount chain “Everything for a Dollar Store.” Canadian distributors are cooperating in the investigation and have removed the product from their shelves.
Genuine Colgate toothpaste approved for sale in Canada is safe and is labelled in English and French. Additionally, fluoride-containing toothpaste that has been approved for sale in Canada will contain either an eight-digit Drug Identification Number (DIN) or a Natural Product Number (NPN).
Canadian consumers with questions on how to identify genuine Colgate toothpaste can contact Colgate Canada’s consumer line at (1-800-268-6757) or visit www.colgate.ca.
Consumers are also advised to monitor the Health Canada Web site (www.healthcanada.gc.ca) for additional updates regarding this issue.
WARMINSTER, PA — (MARKET WIRE) — May 02, 2007 — OraPharma, Inc., a specialty pharmaceutical company specializing in the discovery, development, and commercialization of therapeutics for the treatment of periodontal disease, including ARESTIN® (minocycline hydrochloride) Microspheres, 1 mg, recently launched the third generation of its popular web site, www.ARESTIN.com.
The web site, originally launched in 2002, quickly became a primary online destination for dentists, hygienists, and patients seeking 24/7 access to the latest information on the treatment of periodontal disease. The new ARESTIN.com site provides patients and practitioners with easy access to relevant topics, such as:
– Periodontal disease risk factors
– Current clinical research involving ARESTIN® plus SRP compared to
SRP alone
– Tools and resources to help understand and communicate the need for
consistent diagnosis and comprehensive treatment of periodontal disease,
including ARESTIN® plus SRP
According to John Lenart, product director for OraPharma Inc.’s ARESTIN®, “The redesigned ARESTIN.com has a much cleaner layout and easier navigation, including a robust array of educational, clinical, financial, and reimbursement tools that many dental professionals have told us are ‘must-haves’ to be a best-in-class oral health web site. This includes recent clinical studies, news items regarding periodontal disease, interactive educational programming, and an updated news feed highlighting periodontal disease in the lay press. The goal of the site is to enable dental professionals to quickly, conveniently, and easily learn how to successfully implement a periodontal treatment program in their offices. As well, patients are educated about the risks and symptoms of periodontal disease, along with the importance of treatment with ARESTIN® plus SRP.”
ARESTIN.com was created in conjunction with dental health professionals and patients. This was accomplished by working closely with many online dental communities, as well as a 3-month long survey for dental professionals and patients that helped OraPharma determine what each group truly wanted to know and how they would like periodontal disease and ARESTIN® information presented.
The site is designed to be equally informative and useful for dental professionals and consumers, with two separate entry and navigation tracks.
For Dental Professionals:
ARESTIN.com provides in-depth clinical information on ARESTIN®, OraPharma’s locally administered antibiotic indicated as an adjunct to scaling and root planing for the treatment of adult periodontal disease. With the site’s new and improved navigation capabilities, viewers will find useful resources to enhance the dental professional’s knowledge regarding ARESTIN® and periodontal disease treatment. Additionally, there will be expanded functionality to improve the ARESTIN.com user experience, including:
– Personalized myARESTIN® homepage designed exclusively for dental
professionals to customize their needs
– Streaming video demonstration instructions
– Features and benefits of Microsphere technology
– In-depth clinical and safety profiles
– Secure online ordering available only to dental professionals
– Downloadable and printable patient education resources
– Updates on how to maximize available dental reimbursement for
periodontal disease treatment
– Complete prescribing information
– Downloadable web banners
For Consumers:
With many consumers conducting their health-related research online, OraPharma designed the site to provide easy access to periodontal disease risk factors and treatment information. Consumer-friendly topics currently posted include the following:
– What is periodontal disease?
– What are the symptoms?
– Periodontal maintenance
– About ARESTIN®
– Frequently asked questions
In addition, the patient section of ARESTIN.com includes a wealth of educational tools, such as:
– An oral health self-evaluation test
– A glossary of oral health terms
– Important links and other online resources
“Our intent is to make it easy for dental professionals and consumers alike to find the latest information on the risks of periodontal disease, the need for accurate diagnosis and provide comprehensive treatment with ARESTIN® plus SRP,” states Lenart.(1)
About ARESTIN®
ARESTIN® (minocycline hydrochloride) Microspheres, 1 mg, is indicated as an adjunct to scaling and root planing (SRP) procedures for reduction of pocket depth in patients with adult periodontitis. ARESTIN® may be used as part of a periodontal maintenance program which includes good oral hygiene, and scaling and root planing.
ARESTIN® contains minocycline, a tetracycline derivative, and therefore should not be used in children and in pregnant or nursing women. The use of drugs of the tetracycline class during tooth development may cause permanent discoloration of the teeth.
The most common treatment-emergent adverse events were headache (9.0%), infection (7.6%), flu syndrome (5.0%), and pain (4.3%). These occurred at a similar rate to SRP and SRP + placebo.
About OraPharma, Inc.
OraPharma, Inc. is a specialty pharmaceutical company that discovers, develops, and commercializes therapeutics for the treatment of periodontal disease at various phases of progression. ARESTIN® (minocycline hydrochloride) Microspheres, 1 mg, is indicated as an adjunct to scaling and root planing procedures for reduction of pocket depth in patients with adult periodontitis. OSSIX® PLUS (resorbable collagen membrane) is used in guided bone regeneration (GBR) and guided tissue regeneration (GTR) procedures. IMPEDE™ Barrier Rinse is an oral rinse indicated for use as an aid in the treatment of gingivitis by inhibiting bacterial adhesion to tooth surfaces and serves as an adjunct to normal mechanical oral hygiene where it has proved inadequate. For more information about OraPharma and its products, visit www.orapharma.com.
SCOTTSDALE, AZ — (MARKET WIRE) — April 23, 2007 — How do you persuade dental hygienists to convince their patients to try the newest “gee whiz” teeth cleaning device? Simple, create a superior device that’s better than anything out there and energize the sales process with a superior incentive program. The team from Ultreo, Inc., headed by Jack Gallagher, former president of Optiva Corporation (the developers of Sonicare®) have partnered with Incentive Logic to help launch the new product into the professional marketplace. Initial response, both consumer and professional, has been highly positive and the partnership with Incentive Logic will help ensure strategic distribution of the new brand.Ultreo utilizes two technologies to remove plaque bacteria from hard-to-reach areas: ultrasound waveguide technology that transforms ordinary bubbles into pulsating bubbles and precisely tuned sonic bristle action. Dental offices that support the product can accrue reward points by 1) Selling Ultreo directly to patients from their practice and 2) recommending the product to patients for ordering on the Ultreo website.
A discrete and informative Ultreo-branded website will be available to participating dental offices to expedite award redemption, communicate product news, and keep participants apprised of program news and changes. Participants will be able to select from a range of exciting awards.
Ultreo is the most innovative power toothbrush on the market, providing consumers with the most advanced technology available for improving and maintaining their oral health on a daily basis at home. Ultreo is a scientifically based product developed at the University of Washington in association with former executives, scientists and engineers of Optiva Corporation, the developers of the Sonicare® toothbrush. Ultreo, Inc. has eight patents pending and has been awarded three research grants from the Washington Technology Center and two research grants from the National Institutes of Health. Ultreo is headquartered in Redmond, Wash. Please visit www.ultreo.com or call 1.877.4.ULTREO (485.8736) for more information.
Incentive Logic, Inc. (www.incentivelogic.com) works with businesses to develop performance-based rewards programs that help them achieve their goals. By combining business intelligence with a next-generation software platform, they help clients target key performance indicators through tailored incentive solutions that ignite performance. Founded in 1998, Incentive Logic, Inc. is a privately held company headquartered in Scottsdale, Arizona.
Another day, another recall?
Johnson & Johnson recalled a recently launched Listerine plaque-detecting rinse marketed primarily for use by children after testing revealed contamination by microorganisms.
The company’s McNeil-PPC Inc. unit recalled all 4 million bottles of Glacier Mint and Bubble Blast flavors of Listerine Agent Cool Blue plaque-detecting rinse, a spokeswoman said Wednesday. The recall covers all lots sold or distributed since the product’s launch last year.
The recall does not include any other Listerine products, including traditional versions that contain alcohol, spokeswoman Meghan Marschall said. Agent Cool Blue is alcohol-free.
Read more.
You like numbers?
U.S. spending on health care hit nearly $2 trillion in 2005, fueled by the cost of hospital care, doctor fees and prescription drugs, government experts said in an annual report released on Tuesday.
Health-care spending grew 6.9 percent to about $1.99 trillion from about $1.86 trillion in 2004, a slower pace than the 7.9 percent increase a year earlier, the report by the National Health Statistics Group found. The increase outpaced a 3.4 percent rise in inflation in 2005.
Read more.
PLAY
